Prostatic symptoms. Isn't use of prostate specific antigen tests just screening by the back door
Jenkins, L.; Rose, P.; Wilson, T.
Bmj 323(7315): 750-751
2001
ISSN/ISBN: 0959-8138 PMID: 11675724 Document Number: 534789
Document emailed within 1 workday
Related Documents
Ito, K.; Ohtake, N.; Hatori, M.; Mashimo, T.; Jimbo, S.; Tomaru, Y.; Makino, T.; Yajima, H.; Imai, K.; Yamanaka, H. 1992: Prostatic specific antigen (PA) in mass screening for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 38(11): 1225-1229Sheth, A.R.; Garde, S.V.; Mehta, M.K.; Shah, M.G. 1992: Hormonal modulation of biosynthesis of prostatic specific antigen, prostate specific acid phosphatase and prostatic inhibin peptide Indian Journal of Experimental Biology 30(3): 157-161
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Stenman, U.H.; Leinonen, J.; Alfthan, H.; Rannikko, S.; Tuhkanen, K.; Alfthan, O. 1991: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer Cancer Research 51(1): 222-226
Purnell, D.M.; Heatfield, B.M.; Trump, B.F. 1984: Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen Cancer Research 44(1): 285-292
Amayo, A.; Obara, W. 2004: Serum prostate specific antigen levels in men with benign prostatic hyperplasia and cancer of prostate East African Medical Journal 81(1): 22-26
Bentvelsen, F.M.; Bogdanowicz, J.F.; Oosterom, R.; Schröder, F.H. 1990: A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma Nederlands Tijdschrift Voor Geneeskunde 134(33): 1596-1600
Mannini, D.; Aiello, E.; Maver, P.; Corrado, G.; Vecchi, F.; Bellanova, B. 1987: Simultaneous determination of prostatic acid phosphatase and prostate-specific antigen in carcinoma of the prostate. 2 years' experience Minerva Urologica e Nefrologica 39(4): 335-341
Yamaguchi, K.; Tanaka, M.; Kitagawa, N.; Kotake, T.; Yanagi, S.; Ito, H. 1989: The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers Hinyokika Kiyo. Acta Urologica Japonica 35(6): 987-991
Martin, A.A.; Clejan, S. 1994: Prostate specific antigen density: a method for differentiating prostate carcinoma from benign prostatic hypertrophy demonstrates ethnic variation Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 146(4): 163-171
Rahardjo, D.; Kamil, S.T.; Pakasi, L.S. 2000: Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 563-570
O'Dell, K.J.; Volk, R.J.; Cass, A.R.; Spann, S.J. 1999: Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions? Journal of Family Practice 48(9): 682-688
Parkes, C.; Wald, N.J.; Murphy, P.; George, L.; Watt, H.C.; Kirby, R.; Knekt, P.; Helzlsouer, K.J.; Tuomilehto, J. 1995: Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer BMJ 311(7016): 1340-1343
Ciatto, S.; Bonardi, R.; Mazzotta, A.; Lombardi, C.; Santoni, R.; Cardini, S.; Zappa, M. 1995: Comparing two modalities of screening for prostate cancer: digital rectal examination + transrectal ultrasonography vs. prostate-specific antigen Tumori 81(4): 225-229
Théodon, P.; Rymer, J.C.; Chopin, D.; Kouyoudjian, J.C.; Abbou, C.C.; Auvert, J. 1988: The value of the serum level of the prostate-specific antigen in prostatic pathology Annales d'Urologie 22(3): 199-205
Walsh, P.C.; Oesterling, J.E.; Epstein, J.I.; Bruzek, D.J.; Rock, R.C.; Chan, D.W. 1989: The value of prostate-specific antigen in the management of localized prostatic cancer Progress in Clinical and Biological Research 303: 27-33
Srinualnad, S.; Charoenkraikamol, C.; Toraksa, S.; Uiprasertkul, M.; Amornvesukit, T.; Taweemonkongsap, T.; Udompunturak, S.; Nualyong, C.; Tantiwong, A. 2006: Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day) Journal of the Medical Association of Thailand 89(1): 37-42
Otnes, B.; Harvei, S.; Fosså, S.D. 1996: Increased incidence of prostatic cancer. the significance of prostate-specific antigen Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(15): 1795-1799
Badalament, R.A.; Drago, J.R. 1989: Correlation of prostatic specific antigen with Gleason grade in prostate cancer In Vivo 3(6): 381-382
Rodríguez Duarte, C. 1991: Prostate-specific antigen as a prostatic tumor marker. Analysis of results in 206 patients Archivos Espanoles de Urologia 44(6): 697-700